首页 | 本学科首页   官方微博 | 高级检索  
检索        

促红细胞生成素通过PI3-K/Akt信号通路抑制血管紧张素II诱导的新生大鼠心脏成纤维细胞增殖
引用本文:张新金,马业新,文渊,徐雪晶.促红细胞生成素通过PI3-K/Akt信号通路抑制血管紧张素II诱导的新生大鼠心脏成纤维细胞增殖[J].中国病理生理杂志,2009,25(2):293-298.
作者姓名:张新金  马业新  文渊  徐雪晶
作者单位:华中科技大学同济医学院附属同济医院心内科, 湖北 武汉 430030
摘    要:目的: 探讨促红细胞生成素(EPO)对血管紧张素Ⅱ(Ang Ⅱ)诱导的心脏成纤维细胞(CFs)增殖的影响,以及磷脂酰肌醇-3-激酶/蛋白激酶B(PI3-K/Akt)信号途径和一氧化氮合酶(NOS)的作用。方法: 应用胰酶和胶原酶双酶和差速贴壁法分离培养新生大鼠CFs细胞,应用EPO、Ang Ⅱ、PI3-K抑制剂LY294002、NOS抑制剂L-NAME不同因素干预。细胞计数和MTT法作出CFs的生长曲线,检测CFs的增殖。化学酶法检测CFs培养液中的一氧化氮(NO)浓度以及总NOS和其亚型的活性。Western blotting检测Akt、p-Akt、内皮型一氧化氮合酶(eNOS)和诱生型一氧化氮合酶(iNOS)蛋白的表达。结果: Ang Ⅱ促CFs增殖的作用显著。EPO剂量依赖性的增加CFs培养液中的NO浓度,同时剂量依赖性的抑制Ang Ⅱ诱导的CFs增殖。在给药后第4 d,和单纯的Ang Ⅱ相比,浓度为5×103 U/L、1×104 U/L和2×104 U/L EPO对CFs增殖的抑制率分别达到了24.4%、41.5%和50.5%。EPO显著提高Akt的磷酸化水平,促进eNOS蛋白的表达。应用PI3-K抑制剂LY294002和NOS抑制剂L-NAME均能使培养液中的NO浓度也随之下降,EPO抑制Ang Ⅱ诱导CFs增殖的作用均被阻断。但LY294002同时阻断了eNOS蛋白表达,而L-NAME对eNOS没有影响。结论: EPO可剂量依赖性的抑制Ang Ⅱ诱导的新生大鼠CFs的增殖。其作用机制是通过激活PI3-K/Akt信号途径促使CFs中eNOS表达来促进NO的生成,从而抑制CFs的增殖。

关 键 词:促红细胞生成素  成纤维细胞  血管紧张素Ⅱ  一氧化氮合酶  1-磷脂酰肌醇3-激酶  
收稿时间:2007-12-25
修稿时间:2008-4-21

Erythropoietin inhibits the proliferation of neonatal rat cardiac fibroblasts induced by angiotensin II via PI3-K/Akt signaling pathway
ZHANG Xin-jin,MA Ye-xin,WEN Yuan,XU Xue-jing.Erythropoietin inhibits the proliferation of neonatal rat cardiac fibroblasts induced by angiotensin II via PI3-K/Akt signaling pathway[J].Chinese Journal of Pathophysiology,2009,25(2):293-298.
Authors:ZHANG Xin-jin  MA Ye-xin  WEN Yuan  XU Xue-jing
Institution:Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. E-mail: drmayexin@sina.com
Abstract:AIM: To investigate the effects of erythropoietin (EPO) on the proliferation of rat cardiac fibroblasts induced by angiotensin Ⅱ(Ang Ⅱ) and to identify the roles of phosphatidylinositol-3-kinase/Akt (PI3-K/Akt) signaling pathway and nitric oxide synthase (NOS) in this process. METHODS: Neonatal rat cardiac fibroblasts (CFs) were isolated by collgenase, trypsinase and technique of differential attachment. EPO, Ang Ⅱ, LY294002 (an inhibitor of PI3-K), and L-NAME (an inhibitor of NOS) were added in related group respectively. Growth curves of CFs were established by cell counting and methyl thiazolyl tetrazolium (MTT). The levels of nitric oxide (NO), and the activities of NOS and its isoforms were measured by chemical enzymic method. The expressions of Akt, p-Akt, endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) were detected by Western blotting. RESULTS: Ang Ⅱ markedly enhanced the proliferation of CFs. The NO level in CFs culture fluid was increased and the proliferation of CFs induced by Ang Ⅱ was suppressed by EPO in a dose dependent manner. After 4 d of administrations, the proliferation ratio of CFs was suppressed 24.4%, 41.5% and 50.5% by EPO at doses of 5×103 U/L, 1×104 U/L and 2×104 U/L respectively. The expressions of phosphated Akt, p-Akt, and eNOS were all up-regulated by EPO. The effect of EPO on NO was blocked by LY294002 and L-NAME, and the suppression of CFs proliferation induced by Ang Ⅱ was diminished similarly. However, LY294002 also down-regulated the expression of eNOS but the L-NAME had no effect on it. CONCLUSION: EPO suppresses the proliferation of neonatal rat CFs induced by Ang Ⅱ in dose dependent manner. The suppressive effects may be due to up-regulating the expression of eNOS and enhancing the production of NO via activating the PI3-K/Akt signaling pathway.
Keywords:
本文献已被 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号